Menthol in Cigarettes, Tobacco Products; Request for Comments; Extension of Comment Period, 55671 [2013-22015]

Download as PDF Federal Register / Vol. 78, No. 176 / Wednesday, September 11, 2013 / Proposed Rules 13. Section 762.2 is amended by revising paragraph (b)(13) to read as follows: ■ § 762.2 Records to be retained. * * * * * (b) * * * (13) § 744.15(b), UVL statement as well as any logs or records created for multiple shipments; * * * * * Dated: September 3, 2013. Kevin J. Wolf, Assistant Secretary for Export Administration. [FR Doc. 2013–21996 Filed 9–10–13; 8:45 am] BILLING CODE 3510–33–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 1140 [Docket No. FDA–2013–N–0521] Menthol in Cigarettes, Tobacco Products; Request for Comments; Extension of Comment Period AGENCY: Food and Drug Administration, HHS. Advance notice of proposed rulemaking; extension of comment period. ACTION: The Food and Drug Administration (FDA) is extending the comment period for the advance notice of proposed rulemaking (ANPRM) that appeared in the Federal Register of July 24, 2013 (78 FR 44484). In the ANPRM, FDA requested comments, including comments on FDA’s preliminary evaluation, and data, research, or other information that may inform regulatory actions that FDA might take with respect to menthol in cigarettes. The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments. DATES: FDA is extending the comment period on the ANPRM. Submit either electronic or written comments by November 22, 2013. ADDRESSES: You may submit comments, identified by Docket No. FDA–2013–N– 0521, by any of the following methods: tkelley on DSK3SPTVN1PROD with PROPOSALS SUMMARY: Electronic Submissions Submit electronic comments in the following way: • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. VerDate Mar<15>2010 16:39 Sep 10, 2013 Jkt 229001 Written Submissions Submit written submissions in the following ways: • Mail/Hand delivery/Courier (for paper or CD–ROM submissions): Division of Dockets Management (HFA– 305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Instructions: All submissions received must include the Agency name and Docket No. FDA–2013–N–0521 for this rulemaking. All comments received may be posted without change to https:// www.regulations.gov, including any personal information provided. For additional information on submitting comments, see the ‘‘Comments’’ heading of the SUPPLEMENTARY INFORMATION section of this document. Docket: For access to the docket to read background documents or comments received, go to https:// www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the ‘‘Search’’ box and follow the prompts and/or go to the Division of Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: Lauren Berkowitz or Annette L. Marthaler, Center for Tobacco Products, Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850– 3229, 877–287–1373, CTPRegulations@ fda.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background In the Federal Register of July 24, 2013 (78 FR 44484), FDA published an ANPRM with a 60-day comment period to request comments on FDA’s preliminary evaluation, and data, research, or other information that may inform regulatory actions FDA might take with respect to menthol in cigarettes. The Agency has received comments requesting a 60-day extension of the comment period for the ANPRM. These comments convey concern that the current 60-day comment period does not allow sufficient time to develop meaningful or thoughtful responses to questions raised in the ANPRM. FDA has also received comments opposing an extension of the current comment period on the grounds that ample time has been given to comment on the issues raised in the ANPRM. FDA has considered the requests and is extending the comment period for the ANPRM for 60 days, until November 22, 2013. The Agency believes that a 60-day extension allows adequate time for interested persons to submit comments PO 00000 Frm 00015 Fmt 4702 Sfmt 4702 55671 without significantly delaying any potential regulatory action on these important issues. II. Request for Comments Interested persons may submit either electronic comments regarding this document to https://www.regulations.gov or written comments to the Division of Dockets Management (see ADDRESSES). It is only necessary to send one set of comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday, and will be posted to the docket at https:// www.regulations.gov. Dated: September 4, 2013. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2013–22015 Filed 9–10–13; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF VETERANS AFFAIRS 38 CFR Part 17 RIN 2900–AO78 Hospital Care and Medical Services for Camp Lejeune Veterans Department of Veterans Affairs. Proposed rule. AGENCY: ACTION: The Department of Veterans Affairs (VA) proposes to amend its regulations to implement a statutory mandate that VA provide health care to certain veterans who served at Camp Lejeune, North Carolina, for at least 30 days during the period beginning on January 1, 1957, and ending on December 31, 1987. The law requires VA to furnish hospital care and medical services for these veterans for certain illnesses and conditions that may be attributed to exposure to toxins in the water system at Camp Lejeune. This proposed rule does not implement the statutory provision requiring VA to provide health care to these veterans’ family members; regulations applicable to such family members are currently in development and will be promulgated through a separate notice. DATES: Comments must be received on or before October 11, 2013. ADDRESSES: Written comments may be submitted through https:// www.regulations.gov; by mail or handdelivery to Director, Regulations Management (02REG), Department of Veterans Affairs, 810 Vermont Avenue NW., Room 1068, Washington, DC SUMMARY: E:\FR\FM\11SEP1.SGM 11SEP1

Agencies

[Federal Register Volume 78, Number 176 (Wednesday, September 11, 2013)]
[Proposed Rules]
[Page 55671]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-22015]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 1140

[Docket No. FDA-2013-N-0521]


Menthol in Cigarettes, Tobacco Products; Request for Comments; 
Extension of Comment Period

AGENCY: Food and Drug Administration, HHS.

ACTION: Advance notice of proposed rulemaking; extension of comment 
period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is extending the 
comment period for the advance notice of proposed rulemaking (ANPRM) 
that appeared in the Federal Register of July 24, 2013 (78 FR 44484). 
In the ANPRM, FDA requested comments, including comments on FDA's 
preliminary evaluation, and data, research, or other information that 
may inform regulatory actions that FDA might take with respect to 
menthol in cigarettes. The Agency is taking this action in response to 
requests for an extension to allow interested persons additional time 
to submit comments.

DATES: FDA is extending the comment period on the ANPRM. Submit either 
electronic or written comments by November 22, 2013.

ADDRESSES: You may submit comments, identified by Docket No. FDA-2013-
N-0521, by any of the following methods:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.

Written Submissions

    Submit written submissions in the following ways:
     Mail/Hand delivery/Courier (for paper or CD-ROM 
submissions): Division of Dockets Management (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
    Instructions: All submissions received must include the Agency name 
and Docket No. FDA-2013-N-0521 for this rulemaking. All comments 
received may be posted without change to https://www.regulations.gov, 
including any personal information provided. For additional information 
on submitting comments, see the ``Comments'' heading of the 
SUPPLEMENTARY INFORMATION section of this document.
    Docket: For access to the docket to read background documents or 
comments received, go to https://www.regulations.gov and insert the 
docket number, found in brackets in the heading of this document, into 
the ``Search'' box and follow the prompts and/or go to the Division of 
Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Lauren Berkowitz or Annette L. 
Marthaler, Center for Tobacco Products, Food and Drug Administration, 
9200 Corporate Blvd., Rockville, MD 20850-3229, 877-287-1373, 
CTPRegulations@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Background

    In the Federal Register of July 24, 2013 (78 FR 44484), FDA 
published an ANPRM with a 60-day comment period to request comments on 
FDA's preliminary evaluation, and data, research, or other information 
that may inform regulatory actions FDA might take with respect to 
menthol in cigarettes.
    The Agency has received comments requesting a 60-day extension of 
the comment period for the ANPRM. These comments convey concern that 
the current 60-day comment period does not allow sufficient time to 
develop meaningful or thoughtful responses to questions raised in the 
ANPRM. FDA has also received comments opposing an extension of the 
current comment period on the grounds that ample time has been given to 
comment on the issues raised in the ANPRM.
    FDA has considered the requests and is extending the comment period 
for the ANPRM for 60 days, until November 22, 2013. The Agency believes 
that a 60-day extension allows adequate time for interested persons to 
submit comments without significantly delaying any potential regulatory 
action on these important issues.

II. Request for Comments

    Interested persons may submit either electronic comments regarding 
this document to https://www.regulations.gov or written comments to the 
Division of Dockets Management (see ADDRESSES). It is only necessary to 
send one set of comments. Identify comments with the docket number 
found in brackets in the heading of this document. Received comments 
may be seen in the Division of Dockets Management between 9 a.m. and 4 
p.m., Monday through Friday, and will be posted to the docket at https://www.regulations.gov.

    Dated: September 4, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-22015 Filed 9-10-13; 8:45 am]
BILLING CODE 4160-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.